GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ascendis Pharma AS (BSP:A1SN34) » Definitions » Receivables Turnover

Ascendis Pharma AS (BSP:A1SN34) Receivables Turnover : 0.85 (As of Mar. 2025)


View and export this data going back to 2020. Start your Free Trial

What is Ascendis Pharma AS Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Ascendis Pharma AS's Revenue for the three months ended in Mar. 2025 was R$628 Mil. Ascendis Pharma AS's average Accounts Receivable for the three months ended in Mar. 2025 was R$739 Mil. Hence, Ascendis Pharma AS's Receivables Turnover for the three months ended in Mar. 2025 was 0.85.


Ascendis Pharma AS Receivables Turnover Historical Data

The historical data trend for Ascendis Pharma AS's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ascendis Pharma AS Receivables Turnover Chart

Ascendis Pharma AS Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Receivables Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.29 6.03 7.09 11.05 3.71

Ascendis Pharma AS Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Receivables Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.51 0.82 1.46 1.76 0.85

Competitive Comparison of Ascendis Pharma AS's Receivables Turnover

For the Biotechnology subindustry, Ascendis Pharma AS's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ascendis Pharma AS's Receivables Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ascendis Pharma AS's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Ascendis Pharma AS's Receivables Turnover falls into.


;
;

Ascendis Pharma AS Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Ascendis Pharma AS's Receivables Turnover for the fiscal year that ended in Dec. 2024 is calculated as

Receivables Turnover (A: Dec. 2024 )
=Revenue / Average Total Inventories
=Revenue (A: Dec. 2024 ) / ((Accounts Receivable (A: Dec. 2023 ) + Accounts Receivable (A: Dec. 2024 )) / count )
=2323.114 / ((191.685 + 1062.277) / 2 )
=2323.114 / 626.981
=3.71

Ascendis Pharma AS's Receivables Turnover for the quarter that ended in Mar. 2025 is calculated as

Receivables Turnover (Q: Mar. 2025 )
=Revenue / Average Total Inventories
=Revenue (Q: Mar. 2025 ) / ((Accounts Receivable (Q: Dec. 2024 ) + Accounts Receivable (Q: Mar. 2025 )) / count )
=628.436 / ((1062.277 + 415.112) / 2 )
=628.436 / 738.6945
=0.85

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ascendis Pharma AS  (BSP:A1SN34) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.


Ascendis Pharma AS Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Ascendis Pharma AS's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Ascendis Pharma AS Business Description

Traded in Other Exchanges
Address
Tuborg Boulevard 12, Hellerup, DNK, DK-2900
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.

Ascendis Pharma AS Headlines

No Headlines